TickerFacts.

Burning Rock Biotech Ltd (BNR): Shareholders' Equity

Annual figures by period end, from SEC filings.

535.26M CNY
As of 2025-12-31
-22.7%
3-year compound annual growth
-26.1%
5-year compound annual growth
2.42B CNY2018-12-31: -603.46M CNY2019-12-31: -891.49M CNY2020-12-31: 2.42B CNY2021-12-31: 1.85B CNY2022-12-31: 1.16B CNY2023-12-31: 768.41M CNY2024-12-31: 580.83M CNY2025-12-31: 535.26M CNY535.26M CNY
2018-12-31 Shareholders' Equity (CNY) 2025-12-31
Period endedShareholders' EquityChange YoYSource filing
2025-12-31535.26M CNY-7.8%2026-04-28, Balance as of period end
2024-12-31580.83M CNY-24.4%2026-04-28, Balance as of period end
2023-12-31768.41M CNY-33.7%2026-04-28, Balance as of period end
2022-12-311.16B CNY-37.2%2025-04-29, Balance as of period end
2021-12-311.85B CNY-23.8%2024-04-29, Balance as of period end
2020-12-312.42B CNYn/m2023-04-20, Balance as of period end
2019-12-31-891.49M CNYn/m2022-04-29, Balance as of period end
2018-12-31-603.46M CNYn/a2021-03-23, Balance as of period end

Shareholders' Equity at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedShareholders' EquityChange YoY
Burning Rock Biotech Ltd (BNR)2025-12-31535.26M CNY-7.8%
Concord Medical Services Holdings Ltd (CCM)2025-12-311.85B CNY+14.4%

Compare BNR, CCM side by side · Screen every company in Services-Medical Laboratories ↗